MedTrace Logo

A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

NCT03725475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3111

Last updated 2020-10-05

No results posted yet for this study

Summary

This large multinational, non-interventional study (NIS), will retrospectively collect data derived from established medical records over a period of up to approximately 6 years (2013 to 2018), building a platform to capture and consolidate information on treatment patterns, Overall Survival (OS) and treatment effectiveness outcomes in the real-world setting.

Conditions

  • Non-small-cell Lung Cancer (NSCLC)

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-26
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Argentina
  • Chile
  • Colombia
  • Dominican Republic
  • India
  • Mexico
  • Peru
  • Taiwan
  • Thailand
  • Uruguay

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03725475 on ClinicalTrials.gov